A practical reference on Melanotan II: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-11-14. Anything still debated is marked as such rather than presented as settled.
Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Melanotan II; MT-II; N-acetyl-norleucyl-cyclo[Asp-His-D-Phe-Arg-Trp-Lys] amide | Naming follows peptide convention; the numeral distinguishes it from melanotan-1 |
| Molecular formula | C50H69N15O9 | Includes the lactam bridge; no counter-ion assumed |
| Monoisotopic mass | 1023.53 Da | Free base; salts and counter-ions shift the observed value |
| Appearance | White to off-white lyophilised powder | Batch-to-batch colour variation is not itself proof of impurity |
| Typical analytical method | RP-HPLC purity determination with ESI-MS identity confirmation | Retention time alone does not establish sequence identity |
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
== External links == What is a WW domain? Ranganathan lecture on statistical coupling analysis (audio included) Protein folding — a step closer? - A summary of the Ranganathan lab's SCA-based design of artificial yet functional WW domains.
Within the United States, the impacts generally observed during the six-month period include wetter-than-average conditions along the Gulf Coast between Texas and Florida, while drier conditions are observed in Hawaii, the Ohio Valley, Pacific Northwest and the Rocky Mountains. Study of more recent weather events over California and the southwestern United States indicate that there is a variable relationship between El Niño and above-average precipitation, as it strongly depends on the strength of the El Niño event and other factors. Though it has been historically associated with high rainfall in California, the effects of El Niño depend more strongly on the "flavor" of El Niño than its presence or absence, as only "persistent El Niño" events lead to consistently high rainfall. To the north across Alaska, La Niña events lead to drier than normal conditions, while El Niño events do not have a correlation towards dry or wet conditions. During El Niño events, increased precipitation is expected in California due to a more southerly, zonal, storm track. During La Niña, increased precipitation is diverted into the Pacific Northwest due to a more northerly storm track. During La Niña events, the storm track shifts far enough northward to bring wetter than normal winter conditions (in the form of increased snowfall) to the Midwestern states, as well as hot and dry summers. During the El Niño portion of ENSO, increased precipitation falls along the Gulf coast and Southeast due to a stronger than normal, and more southerly, polar jet stream.
=== The 53Mn – 53Cr chronometer === The short-lived 53Mn-53Cr chronometer is based on the radioactive decay of 53Mn to 53Cr with a half-life of 3.80 ± 0.23 million years. Because manganese and chromium are moderately volatile elements, their fractionation in the cooling solar nebula makes this chronometer particularly suited for dating volatile element depletion events in early Solar System materials. The initial homogeneous distribution of 53Mn in the Solar System, a prerequisite for its use as a chronometer, was established in early studies of Solar System materials. Applied to meteorites, 53Mn-53Cr systematics have provided key insights into the origin of chondrite parent bodies and the volatile element depletion history of the early Earth. The volatile element depletion of proto-Earth was established no later than ~3 million years after the formation of calcium-aluminium-rich inclusions (CAIs), contemporaneous with the dissipation of the protoplanetary disk, while full planetary accretion was completed within ~70 million years.
According to Joseph Bernstein of The New York Times, Peters was earning more than $100,000 a month by February 2026 from his Kick livestreams. Peters revealed during a March 2026 livestream that he earned over $100,000 a month from Kick livestreams. However in August 2026 Peters stated that he would move away from Kick and their owner Stake Online Casino after being sponsored by Duel Casino. Peters has appeared as a blackjack dealer for Duel, for which he was officially signed as the "main character of Duel.com's second season." In an interview conducted with Adam Hegarty for 60 Minutes Australia in April 2026, Hegarty asked Peters if he was an incel due to his associations with "looksmaxxing" (a term initially coined by the incel community) and with Andrew Tate; Peters replied that "looksmaxxing" had nothing to do with incel culture, and abruptly ended the interview. Questioned by Sean Hannity on his sexual status, for the July 21, 2026, episode of Hang Out with Sean Hannity, Peters said: "People will often try to associate looksmaxxing with incel culture and being super resentful of women, when it's actually the antithesis of that, right? Looksmaxxing is trying to escape inceldom, if anything, so for that link to try to be made makes no sense to me whatsoever." Peters announced a national "college partytype tour" which included his arrival at Texas A&M University on August 28, 2026. A nightclub that had arranged for his Clemson University stop cancelled his event scheduled for August 26, 2026, citing safety concerns for guests and staff.
== External links == The MEROPS online database for peptidases and their inhibitors: Pepsin A A01.001 Archived 2008-03-20 at the Wayback Machine, Pepsin B A01.002 Archived 2007-12-21 at the Wayback Machine, Pepsin C (Gastricsin) A01.003 Archived 2020-06-02 at the Wayback Machine Pepsin+A at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Pepsinogens at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Pepsinogen+A at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Pepsinogen+C at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Beemans Gum Pepsin: Molecule of the Month Archived 2015-11-30 at the Wayback Machine, by David Goodsell, RCSB Protein Data Bank Overview of all the structural information available in the PDB for UniProt: P20142 (Human Gastricsin) at the PDBe-KB. Overview of all the structural information available in the PDB for UniProt: P0DJD7 (Pepsin A-4) at the PDBe-KB.
Sources: en.wikipedia.org
=== Non-tuberculous mycobacteria === Isoniazid may also be used off-label to treat nontuberculous mycobacterial pulmonary disease. Isoniazid was widely used in the treatment of Mycobacterium avium complex as part of a regimen including rifampicin and ethambutol. Evidence suggests that isoniazid prevents mycolic acid synthesis in M. avium complex as in M. tuberculosis and although this is not bactericidal to M. avium complex, it greatly potentiates the effect of rifampicin.
Vitamin D is a group of structurally related, fat-soluble compounds responsible for increasing intestinal absorption of calcium, along with numerous other biological functions. In humans, the most important compounds within this group are vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol). Unlike the other twelve vitamins, vitamin D is only conditionally essential in the diet, as with adequate skin exposure to the ultraviolet B (UVB) radiation component of sunlight there is synthesis of cholecalciferol in the deeper layers of the skin's epidermis. Vitamin D can also be obtained through diet, food fortification and dietary supplements. For most people, skin synthesis contributes more than dietary sources. Accordingly, the name "vitamin D" is arguably a misnomer, as rather than being an essential part of the diet, it acts more like a fat-soluble secosteroid hormone precursor. Nevertheless, US and other dietary guidelines generally assume that all of a person's vitamin D is taken orally, given the potential for insufficient sunlight exposure due to urban living, cultural choices for the amount of clothing worn when outdoors, and use of sunscreen because of concerns about safe sunlight exposure. In many countries, milk and plant-based milk substitutes are fortified with vitamin D3, as are breakfast cereals. Cholecalciferol is converted in the liver to calcifediol (also known as calcidiol or 25-hydroxycholecalciferol), while ergocalciferol is converted to ercalcidiol (25-hydroxyergocalciferol).
=== Warning signs === Before the development of noma, there may be simple gingivitis: Inflammation and reddening of the gums, which bleed when touched or during toothbrushing. The WHO recommends disinfectant mouthwash; if not available, use warm, salted water that has been boiled. A high-protein diet, Vitamin A supplements, and patient education on oral hygiene are also recommended to prevent noma from progressing to the acute stages.
Sachets, canisters, pads, cards, and emitters Labels and printed indicators Bottle caps and closures Polymer films and multilayer laminates Paper, board, plastic, glass, and metal coatings Trays and moulded package components Adhesives and absorbent structures Electronic tags, sensors, and data loggers The active component may be positioned inside a package without directly touching the product. It may also be immobilised on a food-contact surface or incorporated into the packaging material. System design must consider the quantity of active material, release or absorption rate, package volume, barrier performance, product composition, storage temperature, expected shelf life, migration limits, consumer safety, manufacturing conditions, recycling, and disposal. Edible films, bio-based polymers, biodegradable materials, nanoparticles, natural antimicrobials, and responsive colour indicators are continuing areas of research. Silver nanoparticles and other antimicrobial nanomaterials have been studied for packaging applications, but their migration, toxicity, regulatory status, recycling impact, and environmental effects require evaluation.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.
The natural hormone is a linear tridecapeptide that is rapidly degraded in circulation. Melanotan-2 is shortened, cyclised, N-terminally acetylated, and carries a D-amino acid substitution, all of which slow enzymatic breakdown.
No national medicines regulator has approved melanotan-2 for therapeutic or cosmetic use. In several jurisdictions it is treated as an unapproved prescription medicine, and its legal classification differs from country to country.
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.